High Point Advisor Group LLC I Bio, Inc. Transaction History

High Point Advisor Group LLC

  • $1.67 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 12, 2021
SELL
$1.18 - $2.62 $25,606 - $56,854
-21,700 Reduced 45.51%
25,985 $38,000
Q4 2020

Feb 10, 2021
BUY
$1.05 - $2.24 $50,069 - $106,814
47,685 New
47,685 $125,000

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $23.8M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email